Auro Laboratories Limited (AUROLAB) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE292C01011
Key metrics
- Market Cap
- ₹159 Cr
- P/E Ratio
- 33.96
- EPS
- 7.51
- Book Value
- 74.36
- P/B Ratio
- 3.43
- ROE
- 7.62%
- ROCE
- 6.56%
- Debt / Equity
- 1.37
- Net Margin
- 11.49%
- Revenue Growth
- 58.47%
- Profit Growth
- 92.13%
- Dividend Yield
- —
- 52W High
- ₹317.00
- 52W Low
- ₹159.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Auro Laboratories Limited
Auro Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India and internationally. It offers antihistamine; muscle relaxant; diuretic; iron deficiency; anti-diabetic; anti-fungal, ulcer, malaria, and inflammatory; iodine supplement; analgesics; antacids; potassium and sodium iodide; and microcrystalline cellulose. The company also provides specialty chemicals comprising guanidine nitrate; dimethyl amine HCl; 2-ethoxy benzoic acid; and 3,4,5 - trimethoxy benzoic acid. In addition, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide; cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol; 3,4,5 - trimethoxy benzoic acid; 2-ethoxy benzoic acid for use in API sildenafil citrate; and 5-bromo phthalide that is used in API citalopram. It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. The company was incorporated in 1989 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 78
- Promoter Holding
- 60.23%
The full Auro Laboratories Limited analysis
Create a free account to open the complete AUROLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.